Table 2.
BIA activity of Cytoskyrins and known anticancer drugs.
| Concentration (μg/spot) | Cytoskyrin | ||||||
|---|---|---|---|---|---|---|---|
| A | B | Rugulosin | Luteoskyrin | Bleomycin | Mitomycin C | Doxorubicin | |
| 100 | 1+:T | 0 | T | T | 1+:T | nt | nt |
| 25 | 1+:T | 0 | T | T | 1+:T | nt | nt |
| 2.5 | 3+ | 0 | T | T | 3+ | 1+:11T | 2+ |
| 1.25 | 3+ | 0 | T | T | 3+ | 2+:10T | 1+ |
| 0.6 | 3+ | 0 | T | T | 3+ | 2+:7T | +/− |
| 0.3 | 3+ | 0 | T | T | 3+ | 2+ | 0 |
| 0.15 | 2+ | 0 | T | T | 3+ | 2+ | 0 |
| 0.08 | +/− | 0 | T | T | 2+ | 1+ | 0 |
Test organism is E. coli with a lambda lysogen whose PL promoter is fused to lacZ
T = toxic zone, nt = not tested, 0 = inactive
3+ to +/− = level of β-galactosidase induction from strongest to weakest